{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:15:38Z","timestamp":1759940138084,"version":"3.41.0"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 57-year-old woman who had persistent symptoms of transthyretin cardiac amyloidosis underwent <jats:sup>99m<\/jats:sup>Tc-pyrophosphate (<jats:sup>99m<\/jats:sup>Tc-PYP) scintigraphy. The <jats:sup>99m<\/jats:sup>Tc-PYP planar and SPECT\/CT fusion image showed diffuse myocardial uptake and multiple fractures of the sternum and ribs. These fractures interfered with semiquantitative scores of <jats:sup>99m<\/jats:sup>Tc-PYP uptake, leading to false positive in <jats:sup>99m<\/jats:sup>Tc-PYP imaging.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005230","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T13:00:26Z","timestamp":1713877226000},"page":"e362-e363","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Bilateral Multiple Fractures Obstruct Quantitation of 99mTc-Pyrophosphate Imaging for Cardiac Amyloidosis"],"prefix":"10.1097","volume":"49","author":[{"given":"Qin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahong","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisha","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,4,19]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"802","DOI":"10.5152\/dir.2021.20662","article-title":"Performance of bone tracer for diagnosis and differentiation of transthyretin cardiac amyloidosis: a systematic review and meta-analysis","volume":"27","year":"2021","journal-title":"Diagn Interv Radiol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/ehf2.12518","article-title":"Transthyretin cardiac amyloidosis: an update on diagnosis and treatment","volume":"6","year":"2019","journal-title":"ESC Heart Fail"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"99mTc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s12350-021-02712-9","article-title":"Correction to: ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 2 of 2\u2014diagnostic criteria and appropriate utilization","volume":"28","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s12350-020-02455-z","article-title":"Addendum to ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2\u2014evidence base and standardized methods of imaging","volume":"28","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/RLU.0000000000003816","article-title":"99mTc-pyrophosphate retention in atelectatic pulmonary tissues of a patient with transthyretin cardiac amyloidosis","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1097\/RLU.0000000000004168","article-title":"Large pleural effusion: a pitfall in the quantitation of 99mTc-PYP imaging for ATTR cardiac amyloidosis","volume":"47","year":"2022","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:01:45Z","timestamp":1750532505000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,19]]},"references-count":7,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005230","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2024,4,19]]}}}